Trade Mark Journal No.2026/009 27 February 2026
WO0000001901262 (42)
Office of origin: United States of America
Date of International Registration:6 January 2026
Date of designation in the UK:
6 January 2026
Registration of this mark shall give no right to the exclusive use of "PHARMA SERVICES"
International priority date claimed: 10 July 2025
(United States of America)
(99277099)
- Class 42
- Pharmaceutical drug development services; pharmaceutical research and development; product development in the field of pharmaceuticals, biopharmaceuticals, radiopharmaceuticals, pharmaceutical preparations, vitamins, medicines, pharmaceutical packaging and drug delivery technologies; research and development of new products for others; product development consultation; testing of pharmaceuticals; scientific research consulting in the field of pharmaceuticals and biopharmaceuticals; technology consultation in the field of pharmaceuticals and new drug development; custom design and development of chemical reagents and biochemical assays; development of pharmaceuticals for cell and gene therapies; research and development and consultation related thereto in the field of over-the-counter drugs; research and development in the field of pharmaceutical preparations and products for cell therapy, gene therapy, and beauty care; scientific research consulting; technology consultation in the field of new drug development for the pharmaceutical industry; technology consultation in the field of pharmaceutical drug delivery and dosage technologies; scientific research consulting in the field of pharmaceutical drug delivery and dosage technologies.
R.P. SCHERER TECHNOLOGIES, LLC
Representative: Vanessa A. Ignacio, Esq. Lowenstein Sandler LLP, One Lowenstein Drive, Roseland NJ 07068, UNITED STATES OF AMERICA